Return on equity (ROE) is the profit a company earns for every dollar of shareholder money invested in it, shown as a percentage. It is net income divided by shareholder equity, and the table shows both amounts: the profit earned and the equity it was earned on. A higher ROE means more profit per dollar of equity, but ROE also rises when equity shrinks through buybacks, dividends or losses, and it has no meaning for a company with negative equity. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.
Bionano Genomics, Inc. roe for the quarter ending 2026-06-30 was -101.76%, a change of 62.06% year-over-year.
Bionano Genomics, Inc. roe for the quarter ending 2026-03-31 was -84.34%, a change of 89.35% year-over-year.
Bionano Genomics, Inc. roe for the quarter ending 2025-12-31 was -59.42%, a change of 257.24% year-over-year.
Bionano Genomics, Inc. roe for the quarter ending 2025-09-30 was -77.49%, a change of 200.39% year-over-year.
Bionano Genomics, Inc. roe for fiscal 2025 was -59.42%, a change of 257.24% from fiscal 2024.
Bionano Genomics, Inc. roe for fiscal 2024 was -316.66%, a change of -74.87% from fiscal 2023.
Bionano Genomics, Inc. roe for fiscal 2023 was -241.78%, a change of -188.62% from fiscal 2022.
Bionano Genomics, Inc. roe for fiscal 2022 was -53.17%, a change of -31.68% from fiscal 2021.